Skip to main content

ASCO Was A Bust For Biotech

The 2017 meeting of the American Society of Clinical Oncology ended with a whimper, not a bang -- at least for the biotech sector.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.